AuntMinnie.com staff writersRadiation Oncology/TherapyZAP Surgical touts first Zap-X radiosurgery treatments in Latin AmericaZAP is touting the first stereotactic radiosurgery treatments in Latin America using its Zap-X gyroscopic radiosurgery platform.June 19, 2025Radiation Oncology/TherapyRatio Therapeutics inks radioisotope supply deal with NusanoRatio Therapeutics is developing radiopharmaceuticals for imaging and treating cancer.June 18, 2025PACS/VNARadpair and Lifetrack enter strategic partnershipLifetrack Medical SystemsThe joint venture is intended to help streamline radiologist workflows.June 18, 2025UltrasoundExo launches new AI apps for Exo IrisExo ImagingThere are now 14 U.S. Food and Drug Administration-cleared algorithms embedded in Exo's handheld ultrasound device.June 18, 2025Industry NewsMindray breaks ground on NJ expansion projectMindray has broken ground on its facilities expansion project in Mahwah, NJ.June 17, 2025AssociationsMGMA speaks out on Senate provisionsThe Medical Group Management Association (MGMA) has responded to Senate provisions that affect physician group practices.June 17, 2025AIAidoc releases framework for clinical AI deploymentAidocAidoc's BRIDGE framework gives guidance for assessing AI-based applications by outlining the criteria that AI should meet.June 17, 2025POCUSPhilips launches POC ultrasound systemPhilips has launched its point-of-care (POC) portable ultrasound system, Flash Ultrasound System 5100 POC.June 17, 2025Advanced VisualizationFirst nonacademic hospital offers MediView's XR90 AR navigation systemThe hospital used the augmented reality (AR) system in a minor procedure room rather than a traditional angiography suite.June 16, 2025MRIBracco, Subtle Medical secure CE Mark for AiMIFY softwareBracco Diagnostics Inc.AiMIFY uses AI technology to increase the contrast enhancement of brain MRI scans.June 16, 2025Previous PagePage 63 of 235Next PageTop StoriesCTNew benchmark helps monitor cumulative CT radiation doseThe findings highlight the need for systematic dose tracking and rigorous justification of imaging.Radiation Oncology/TherapyStudy questions routine use of radiotherapy after bone surgeryUltrasoundCEUS outshines color Doppler imaging for indeterminate kidney lesionsWomens ImagingWomen's Imaging MinnieCast, Episode 2: Risk-based vs. annual mammography screening, part 1Digital X-RayChest x-rays reveal atherosclerosis in patients undergoing amputations
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
